Skip to search.
 TSX Up 0.71% TSX Ventures Up 1.85%

Transition Therapeutics Inc. (TTHI)

-NasdaqGM
2.17 Aug 28, 3:59PM EDT
Add to Portfolio
Prev Close:2.17
Open:N/A
Bid:N/A
Ask:N/A
1y Target Est:4.50
Beta:2.06635
Next Earnings Date:N/A
Day's Range:N/A - N/A
52wk Range:1.77 - 9.30
Volume:0
Avg Vol (3m):215,322
Market Cap:80.05M
P/E (ttm):N/A
EPS (ttm):-1.09
Div & Yield:N/A (N/A)
Quotes delayed, except where indicated otherwise. Currency in USD.

Headlines

Key Statistics

Forward P/E (1 yr):N/A
P/S (ttm):N/A
Ex-Dividend Date:N/A

Analysts

Annual EPS Est (Jun-15) :-1.34
Quarterly EPS Est (Jun-15) :-0.26
Mean Recommendation*:2.7
PEG Ratio (5 yr expected):N/A

* (Strong Buy) 1.0 - 5.0 (Sell)

Analyst Opinion | Estimates

Business Summary

Transition Therapeutics Inc., a biopharmaceutical company, researches and develops therapeutic agents for disease indications in Canada. The company's lead central nervous system drug candidate is ELND005, a Phase II clinical trial product us... View More
Your browser doesn't support canvas
SETTINGS
Scrolling
Speed
Display
Price
Submit Feedback